Investors should take notice of NASDAQ:SUPN—it offers a great deal for the fundamentals it presents.

Our stock screening tool has pinpointed SUPERNUS PHARMACEUTICALS INC (NASDAQ:SUPN) as an undervalued stock. NASDAQ:SUPN maintains a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.

Valuation Insights: NASDAQ:SUPN

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NASDAQ:SUPN boasts a 8 out of 10:

• SUPN's Price/Earnings ratio is rather cheap when compared to the industry. SUPN is cheaper than 84.97% of the companies in the same industry.
• SUPN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.56.
• Based on the Price/Forward Earnings ratio, SUPN is valued cheaply inside the industry as 86.01% of the companies are valued more expensively.
• SUPN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.00.
• 86.01% of the companies in the same industry are more expensive than SUPN, based on the Enterprise Value to EBITDA ratio.
• Based on the Price/Free Cash Flow ratio, SUPN is valued cheaply inside the industry as 88.08% of the companies are valued more expensively.
• SUPN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• The decent profitability rating of SUPN may justify a higher PE ratio.
• A more expensive valuation may be justified as SUPN's earnings are expected to grow with 27.03% in the coming years.

Exploring NASDAQ:SUPN's Profitability

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:SUPN, the assigned 6 is a significant indicator of profitability:

• SUPN has a better Return On Assets (-1.19%) than 80.31% of its industry peers.
• SUPN's Return On Equity of -1.67% is amongst the best of the industry. SUPN outperforms 81.35% of its industry peers.
• SUPN's Return On Invested Capital of 0.52% is fine compared to the rest of the industry. SUPN outperforms 76.17% of its industry peers.
• SUPN's Operating Margin of 1.09% is fine compared to the rest of the industry. SUPN outperforms 77.20% of its industry peers.
• SUPN's Gross Margin of 87.17% is amongst the best of the industry. SUPN outperforms 89.64% of its industry peers.

Understanding NASDAQ:SUPN's Health Score

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:SUPN, the assigned 6 for health provides valuable insights:

• SUPN has an Altman-Z score of 3.54. This indicates that SUPN is financially healthy and has little risk of bankruptcy at the moment.
• Looking at the Altman-Z score, with a value of 3.54, SUPN is in the better half of the industry, outperforming 78.76% of the companies in the same industry.
• SUPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

A Closer Look at Growth for NASDAQ:SUPN

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:SUPN has received a 5 out of 10:

• The Earnings Per Share has grown by an impressive 53.93% over the past year.
• SUPN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.24% yearly.
• The Earnings Per Share is expected to grow by 28.98% on average over the next years. This is a very strong growth
• When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More Decent Value stocks can be found in our Decent Value screener.

For an up to date full fundamental analysis you can check the fundamental report of SUPN

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.